Citation: R. Capek et al., SUPPRESSION OF ACTIVITY-DEPENDENT DISINHIBITION BY VIGABATRIN IN THE HIPPOCAMPAL SLICE PREPARATION, Naunyn-Schmiedeberg's archives of pharmacology, 358(1), 1998, pp. 35116-35116
Citation: R. Capek et B. Esplin, USE-DEPENDENT DEPRESSION OF SYNAPTIC NMDA RECEPTOR-MEDIATED RESPONSESBY DIZOCILPINE (MK-801), Canadian journal of physiology and pharmacology, 75(2), 1997, pp. 158-163
Citation: R. Capek et B. Esplin, EFFECTS OF LIDOCAINE ON HIPPOCAMPAL PYRAMIDAL CELLS - DEPRESSION OF REPETITIVE FIRING, NeuroReport, 5(6), 1994, pp. 681-684
Authors:
CLARKE PBS
CHAUDIEU I
ELBIZRI H
BOKSA P
QUIK M
ESPLIN BA
CAPEK R
Citation: Pbs. Clarke et al., THE PHARMACOLOGY OF THE NICOTINIC ANTAGONIST, CHLORISONDAMINE, INVESTIGATED IN RAT-BRAIN AND AUTONOMIC GANGLION, British Journal of Pharmacology, 111(2), 1994, pp. 397-405
Citation: Mf. Jackson et al., ACUTE EFFECTS OF GAMMA-VINYL GABA(VIGABATRIN) ON HIPPOCAMPAL GABAERGIC INHIBITION IN-VITRO, Brain research, 651(1-2), 1994, pp. 85-91
Citation: R. Capek et B. Esplin, FREQUENCY-DEPENDENT ENHANCEMENT OF HIPPOCAMPAL INHIBITION BY GABA UPTAKE BLOCKERS, Epilepsy research, 16(2), 1993, pp. 123-130